- Tytuł:
- Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial
- Autorzy:
- Źródło:
- In The Lancet Neurology July 2023 22(7):568-577
Czasopismo naukowe